Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Lung Neoplasms
  • Protein Kinase Inhibitors
  • Quinazolines
  • Receptor, Epidermal Growth Factor

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4655969

Digital Object Identifier (DOI)

  • 10.1097/JTO.0000000000000221

PubMed ID

  • 25521405

Additional Document Info

start page

  • e73

end page

  • 4

volume

  • 9

number

  • 10